In vivo phase variation of Escherichia coli type 1 fimbrial genes in women with urinary tract infection.

[1]  J. Hacker,et al.  The Pai‐associated leuX specific tRNALeu5 affects type 1 fimbriation in pathogenic Escherichia coli by control of FimB recombinase expression , 1997, Molecular microbiology.

[2]  H. Mobley,et al.  Pathogenicity island sequences of pyelonephritogenic Escherichia coli CFT073 are associated with virulent uropathogenic strains , 1997, Infection and immunity.

[3]  S. Langermann,et al.  Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. , 1997, Science.

[4]  I. Blomfield,et al.  In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract , 1997, Molecular microbiology.

[5]  J. Mecsas,et al.  Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands. , 1996, Emerging infectious diseases.

[6]  C. Svanborg,et al.  Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Marc,et al.  Analysis of the fim cluster of an avian O2 strain of Escherichia coli: serogroup-specific sites within fimA and nucleotide sequence of fimI. , 1996, Journal of medical microbiology.

[8]  H. Mobley,et al.  Urinary tract infections : molecular pathogenesis and clinical management , 1996 .

[9]  B. Foxman,et al.  Bacterial virulence characteristics of Escherichia coli isolates from first-time urinary tract infection. , 1995, The Journal of infectious diseases.

[10]  A. Siitonen.  What makes Escherichia coli pathogenic? , 1994, Annals of medicine.

[11]  R. Russell,et al.  Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection , 1994, Infection and immunity.

[12]  K. Jarvis,et al.  Isogenic P‐fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of α Gal(1–4)β Gal binding in virulence of a wild‐type strain , 1993 .

[13]  I. Blomfield,et al.  Environmental regulation of the fim switch controlling type 1 fimbrial phase variation in Escherichia coli K-12: effects of temperature and media , 1993, Journal of bacteriology.

[14]  H. Mobley,et al.  Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection , 1991, Infection and immunity.

[15]  M. S. McClain,et al.  Roles of fimB and fimE in site-specific DNA inversion associated with phase variation of type 1 fimbriae in Escherichia coli , 1991, Journal of bacteriology.

[16]  J. R. Johnson,et al.  Virulence factors in Escherichia coli urinary tract infection , 1991, Clinical Microbiology Reviews.

[17]  H. Holthöfer,et al.  Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract , 1990, Infection and immunity.

[18]  H. Mobley,et al.  Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains , 1990, Infection and immunity.

[19]  S. Mårild,et al.  Special virulence of the Escherichia coli O1:K1:H7 clone in acute pyelonephritis. , 1989, The Journal of pediatrics.

[20]  A. Schaeffer,et al.  In vivo expression and variation of Escherichia coli type 1 and P pili in the urine of adults with acute urinary tract infections , 1989, Infection and immunity.

[21]  G. Schoolnik.  How Escherichia coli infects the urinary tract. , 1989 .

[22]  J. Duncan.  Differential effect of Tamm-Horsfall protein on adherence of Escherichia coli to transitional epithelial cells. , 1988, The Journal of infectious diseases.

[23]  S. Hull,et al.  Attachment of Escherichia coli via mannose- or Gal alpha 1----4Gal beta-containing receptors to human colonic epithelial cells , 1988, Infection and immunity.

[24]  J. Parkkinen,et al.  Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins , 1988, Infection and immunity.

[25]  H. Mobley,et al.  Urease-positive bacteriuria and obstruction of long-term urinary catheters , 1987, Journal of clinical microbiology.

[26]  A. Siitonen,et al.  Expression of P, type-1, and type-1C fimbriae of Escherichia coli in the urine of patients with acute urinary tract infection. , 1987, The Journal of infectious diseases.

[27]  A. Schaeffer,et al.  Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice , 1987, Infection and immunity.

[28]  A. Schaeffer,et al.  Regulation of production of type 1 pili among urinary tract isolates of Escherichia coli , 1986, Infection and Immunity.

[29]  L. Maurer,et al.  Receptor-binding function of type 1 pili effects bladder colonization by a clinical isolate of Escherichia coli , 1986, Infection and immunity.

[30]  P. Klemm,et al.  Two regulatory fim genes, fimB and fimE, control the phase variation of type 1 fimbriae in Escherichia coli. , 1986, The EMBO journal.

[31]  A. Schaeffer,et al.  Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli , 1985, Infection and immunity.

[32]  W. Simpson,et al.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors , 1985, Infection and immunity.

[33]  S. Falkow,et al.  Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili , 1985, Journal of bacteriology.

[34]  B. Nowicki,et al.  Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71 , 1984, Journal of bacteriology.

[35]  S. Falkow,et al.  Contribution of Adhesion to Bacterial Persistence in the Mouse Urinary Tract , 1983, Infection and immunity.

[36]  R. Freter,et al.  Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin , 1983, Infection and immunity.

[37]  Y. Abe,et al.  Role of type 1 fimbriae in the pathogenesis of ascending urinary tract infection induced by escherichia coli in mice , 1983, Infection and immunity.

[38]  N. Sharon,et al.  Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with urinary tract infections, and of isolates subcultured from the infected urine , 1981, Infection and immunity.

[39]  B. Eisenstein.  Phase variation of type 1 fimbriae in Escherichia coli is under transcriptional control. , 1981, Science.

[40]  L. Hagberg,et al.  Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections , 1981, Infection and immunity.

[41]  F. Silverblatt,et al.  Antipili antibody affords protection against experimental ascending pyelonephritis. , 1979, The Journal of clinical investigation.

[42]  N. Sharon,et al.  Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. , 1979, The Journal of infectious diseases.

[43]  D. Musher,et al.  Urease. The primary cause of infection-induced urinary stones. , 1976, Investigative urology.